In our study, we found that ING4 significantly reduced the mRNA and protein expressions of MMP-2 and COX-2, which was consistent with the findings in melanoma [18], osteosarcoma [32] and brain cancer [33], and the expression of nuclear Sp1 and subsequent DNA binding activity. The gene discussed is ING4; the disease is brain cancer.